Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 11 2
Albumin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/23/2020 1 0
Gallium maltolate Potential treatment - pre-clinical evidence Experimental Antiviral Dec/22/2020 1 0
NIH-CoVnb-112 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/22/2020 1 0
Lycorine Potential treatment - pre-clinical evidence Natural product Antiviral Dec/16/2020 1 0
VHH-72-VHH-72 Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020 1 0
VHH-72-Fc Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020 1 0
Excel (.xslx) CSV (.csv)